Yandex injects 600G wavelengths into DCI network with ADVA TeraFlex™
ADVA (FSE: ADV) today announced that Yandex has transformed its data center interconnect (DCI) infrastructure into a 600Gbit/s transport network using the ADVA FSP 3000 TeraFlex™. The solution massively increases the capacity of Yandex’s infrastructure throughout Moscow, enabling Russia’s largest search engine provider to meet rapidly rising data demands and expand its cloud services. Delivering high levels of throughput, density and scale, the technology easily plugged into Yandex’s existing line system. ADVA’s open TeraFlex™ terminal supports 600Gbit/s over a single wavelength and delivers a total duplex capacity of 3.6Tbit/s in one rack unit. With its low power consumption and ultra-flexible modulation capabilities, TeraFlex™ ensures maximum spectral efficiency, making Yandex’s DCI network future-proof and highly efficient.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201105005031/en/
ADVA's TeraFlex™ technology is helping Yandex to easily scale its DCI network (Photo: Business Wire)
“We’re proud of what our FSP 3000 TeraFlex™ technology is helping Yandex achieve. Without the effort or expense of a complete system upgrade, it’s enabled one of Russia’s biggest technology companies to transform its infrastructure. By unlocking the full value of its fiber assets, Yandex is opening the door to further growth and innovation,” commented Hartmut Müller-Leitloff, SVP, sales, EMEA, ADVA. “Our TeraFlex™ has a large degree of configuration flexibility, using different modulation formats and software-defined fractional QAM to optimize data rate transmission performance. Together with its plug-and-play simplicity, TeraFlex™ made it easy for Yandex to transform its existing DCI infrastructure.”
Yandex’s Moscow data centers are now connected in a point-to-point network with ADVA’s high-density TeraFlex™ terminal. Serving 36 bidirectional 100GbE client ports, the 1RU solution injects new levels of channel capacity and spectral efficiency into Yandex’s network. Built specifically to maximize fiber utilization, TeraFlex™ features software-defined fractional QAM modulation capabilities. This enables it to leverage different modulation formats and optimize all optical paths over any distance.
“We’re helping Yandex to massively expand the capacity of its network and accommodate ever-increasing traffic demands. Our TeraFlex™ terminal is ensuring that one of Russia’s leading technology companies can meet its customers’ expectations and continue growing its business well into the future,” said Stephan Rettenberger, SVP, marketing and investor relations, ADVA. “Tens of millions of people rely on Yandex’s products and services on a daily basis. That’s why it’s a company keen to deliver even more by leveraging the most advanced technology on the market. Our solution enables it to continue innovating and improving quality. And, with the space- and power-efficiency of TeraFlex™, Yandex’s new network also ensures that future growth is fully sustainable.”
About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com.
Published by:
ADVA Optical Networking SE, Munich, Germany
www.adva.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201105005031/en/
Contact information
For press:
Gareth Spence
t +44 1904 699 358
public-relations@adva.com
For investors:
Stephan Rettenberger
t +49 89 890 665 854
investor-relations@adva.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Ant Group Unveils China’s First Multimodal AI Assistant with Code-Driven Outputs18.11.2025 10:05:00 EET | Press release
Ant Group today launched LingGuang, a next-generation multimodal AI assistant and the first of its kind in China that interacts with users through code-driven outputs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251117438567/en/ Equipped with the capability to understand and produce language, image, voice and data, LingGuang delivers precise, structured responses to complex queries through 3D models, audio clips, charts, animations, interactive maps, and even immediately generated applications, in addition to traditional text-based conversation. Designed around three key features, LingGuang aims to make complex knowledge simpler and more intuitive, transforming how users access information and interact with AI tools. Fast Research: LingGuang responds to user questions or keywords with dynamic, multimodal content, making research on any topic clearer and more engaging. Its 3D digital modeling capability transcends traditio
SkySparc Appoints Oliver Bussmann as Chairman of the Board18.11.2025 10:00:00 EET | Press release
SkySparc, a trusted global provider of digital transformation solutions for treasury and finance organizations, today announced the appointment of Oliver Bussmann as Chairman of the Board, following the closing of a majority growth investment from Bregal Milestone, a leading European software private equity firm. As former Global CIO at UBS and SAP, Bussmann has a proven track record of scaling B2B software and services across the Office of the CFO, Financial Services, RegTech, and WealthTech. Throughout his career, he has guided organizations through complex SaaS transitions, strategic M&A, and go-to-market acceleration – delivering multiple successful exits and sustained enterprise growth. Bussmann will help steer SkySparc’s technology and value-creation agenda, as Chairman, leveraging his network across financial services and technology to accelerate innovation, expand AI adoption, and drive long-term growth. “We are thrilled to welcome Oliver to SkySparc’s leadership team,” said Jo
European Commission Grants Approval of Remsima™ IV Liquid Formulation, World’s First Liquid Formulation of IV Infliximab18.11.2025 09:23:00 EET | Press release
Celltrion, Inc. today announced that the European Commission (EC) has granted marketing authorization for Remsima™ IV (intravenous) liquid formulation, the world’s first liquid formulation of IV infliximab. Approved in 100 mg and 350 mg vials, the formulation is designed to streamline infusion preparation, reduce healthcare professionals’ workload, and support hospital operational efficiency.3 The Remsima™ IV liquid formulation is approved in the EU for all indications of IV infliximab, matching the approved uses of all existing IV infliximab powder formulations, including rheumatoid arthritis (RA), adult and pediatric Crohn’s disease (CD), ulcerative colitis (UC), pediatric UC, ankylosing spondylitis (AS), psoriatic arthritis (PsA), and psoriasis (PsO).1 The comparability between lyophilized powder formulation and the liquid formulation of IV infliximab has been established through comprehensive chemistry, manufacturing, and controls data.2 The stability of the liquid formulation of I
Swiss-Based Debiopharm Seeks to Boost Innovation in Japanese Cancer Research Through the New "Ideal Japan” Program18.11.2025 09:00:00 EET | Press release
Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company aiming to cure cancer and infectious diseases, is pleased to announce today the launch of the new IDEAL Japan initiative. This program was initiated to provide financial support to Japanese academic researchers in order to facilitate the transformation of academic innovation into novel therapeutic approaches for combating cancer. IDEAL Japan follows the conclusion of the highly respected JCA (Japanese Cancer Association) Mauvernay Award in Japan, which honored Japanese scientists over the last 20 years, from 2004 through 2024. Debiopharm is now transitioning its historic award into the IDEAL Japan initiative aiming to accelerate preclinical scientific research that could give rise to new treatments for cancer patients. “Our vision is to collaborate to find a cure for cancer,”explained Thierry Mauvernay, President of Debiopharm. “We believe that our ongoing Swiss-Japanese connection needs to evolve and catalyze the trans
Avanzanite Bioscience Secures €32M Series A Investment from MVM Partners18.11.2025 08:00:00 EET | Press release
Avanzanite Bioscience B.V. (Avanzanite), a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today announced a €32 million Series A growth investment from MVM Partners (MVM), a leading global life-science private equity firm. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251117345890/en/ Adam Plich, Founder and CEO of Avanzanite. The announcement follows a record-breaking Q3 2025 for Avanzanite, with revenue tripling year-on-year and climbing over 20% quarter-on-quarter. This strategic funding will accelerate the expansion of Avanzanite’s pan-European infrastructure and propel both current and future rare disease product launches. The capital will also enable Avanzanite to form new strategic alliances and acquire assets to expand its portfolio. Avanzanite was built to solve Europe’s rare-disease medicines access gap. Under one pan-European operation, Avanzanite brings toget
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
